eMetagen gets $535,000 from MU angel investors ( MILWAUKEE - Madison-based drug discov...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> BIOLOGY >> TECHNOLOGY

eMetagen gets $535,000 from MU angel investors

MILWAUKEE - Madison-based drug discovery and development company eMetagen Corp. closed a $535,000 seed investment round with the Marquette University Golden Angels Network, the angel investors group reported Wednesday.

eMetagen plans to use the Golden Angels investment, al......

Full article >>>

Source:wistechnology.com By Eric Kleefeld 08/03/05

Page: 1 2
Related biology technology :

1. Hefty joins eMetagen board
2. eMetagens infectious disease technology licensed by WARF
3. Investor warns of angel-venture funding gap
4. Breaking down Wisconsins angel capital numbers
5. Research explains why women lack equal access to angel capital
6. Capital-raising term sheets for angels and venture capitalists
7. National angel investment grew 11 percent in `06
8. New angel capital centered on GenTel agreement with big pharma
9. BioSystem Development secures angel funding
10. New Silicon Pastures director envisions more home cooking for Wisconsin angels
11. Milwaukee angel network invests in St. Louis company

Post Your Comments:

Breaking Biology Technology:Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 2 Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 3 Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 4 Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 5 Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 6 Sirius Genomics Announces Change in Leadership 2 Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 2 Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 3 Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 4

[0] Quest Diagnostics Declares Quarterly Cash Dividend [0] Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain [0] Sirius Genomics Announces Change in Leadership [0] Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea

Other Biology Technology:New Greenline Tea FASTRACK Solves Cold-Flow Issues 2 Trubion Announces Presentations at Upcoming Investor Conferences 2 Victhom Human Bionics Receives CE Mark for the Neurostep(TM) System, the World's First Fully Implantable Closed-Loop Neuromodulation Therapy for Treatment of Foot Drop 2 Victhom Human Bionics Receives CE Mark for the Neurostep(TM) System, the World's First Fully Implantable Closed-Loop Neuromodulation Therapy for Treatment of Foot Drop 3

New Greenline Tea FASTRACK Solves Cold-Flow Issues Trubion Announces Presentations at Upcoming Investor Conferences Victhom Human Bionics Receives CE Mark for the Neurostep(TM) System, the World's First Fully Implantable Closed-Loop Neuromodulation Therapy for Treatment of Foot Drop

Breaking Biology News(10 mins):Moderate weight loss in obese people improves heart function 2 Moderate weight loss in obese people improves heart function 3 New inherited eye disease discovered 2 Experts: Disease-resistant plants enhance profits, client satisfaction 2 Spectrum Announces Fetal Bovine Serum Product Line 13184 1 Spectrum Announces Fetal Bovine Serum Product Line 13184 2 Pence Amendment Passes Rules Committee 3B Set for Friday Vote 52628 1 Pence Amendment Passes Rules Committee 3B Set for Friday Vote 52628 2 OMT announces a breakthrough in the development of a novel human antibody platform 13181 1 OMT announces a breakthrough in the development of a novel human antibody platform 13181 2

[0] Moderate weight loss in obese people improves heart function [0] New inherited eye disease discovered [0] Experts: Disease-resistant plants enhance profits, client satisfaction

Other Biology News:Oxygen depletion: A new form of ocean habitat loss 2 Nature paper describes technique for extracting hierarchical structure of networks 2

Oxygen depletion: A new form of ocean habitat loss Cold Spring Harbor Protocols features classic approaches for analyzing chromosomes Nature paper describes technique for extracting hierarchical structure of networks

Biology Products:

Chicken Anti-Guanine nucleotide-binding protein G(k), alpha subunit Polyclonal Antibody, Unconjugated from GenWay Biotech, Inc.Rabbit Anti-ICAD Polyclonal Antibody, Unconjugated from BD Biosciences Pharmingen Anti-Indoleamine 2,3-dioxygenase (IDO) Monoclonal Antibody, Unconjugated from CHEMICON Anti-G Protein Gq / 11a Subunit, Internal Sequence, a.a. 115-133 Polyclonal Antibody, Unconjugated from CHEMICON